Correlation Between Allarity Therapeutics and ABVC Biopharma
Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allarity Therapeutics and ABVC Biopharma, you can compare the effects of market volatilities on Allarity Therapeutics and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and ABVC Biopharma.
Diversification Opportunities for Allarity Therapeutics and ABVC Biopharma
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Allarity and ABVC is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and ABVC Biopharma go up and down completely randomly.
Pair Corralation between Allarity Therapeutics and ABVC Biopharma
Given the investment horizon of 90 days Allarity Therapeutics is expected to under-perform the ABVC Biopharma. In addition to that, Allarity Therapeutics is 1.21 times more volatile than ABVC Biopharma. It trades about -0.04 of its total potential returns per unit of risk. ABVC Biopharma is currently generating about 0.15 per unit of volatility. If you would invest 52.00 in ABVC Biopharma on December 1, 2024 and sell it today you would earn a total of 28.00 from holding ABVC Biopharma or generate 53.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Allarity Therapeutics vs. ABVC Biopharma
Performance |
Timeline |
Allarity Therapeutics |
ABVC Biopharma |
Allarity Therapeutics and ABVC Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Allarity Therapeutics and ABVC Biopharma
The main advantage of trading using opposite Allarity Therapeutics and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.Allarity Therapeutics vs. Immix Biopharma | Allarity Therapeutics vs. Cns Pharmaceuticals | Allarity Therapeutics vs. Sonnet Biotherapeutics Holdings | Allarity Therapeutics vs. Zura Bio Limited |
ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |